Adaptive radiotherapy for breast cancer
dc.contributor.author | De-Colle, C. | |
dc.contributor.author | Kirby, A. | |
dc.contributor.author | Russell, N. | |
dc.contributor.author | Shaitelman, S. F. | |
dc.contributor.author | Currey, A. | |
dc.contributor.author | Donovan, E. | |
dc.contributor.author | Hahn, E. | |
dc.contributor.author | Han, K. | |
dc.contributor.author | Anandadas, Carmel N | |
dc.contributor.author | Mahmood, F. | |
dc.contributor.author | Lorenzen, E. L. | |
dc.contributor.author | van den Bongard, D. | |
dc.contributor.author | Groot Koerkamp, M. L. | |
dc.contributor.author | Houweling, A. C. | |
dc.contributor.author | Nachbar, M. | |
dc.contributor.author | Thorwarth, D. | |
dc.contributor.author | Zips, D. | |
dc.date.accessioned | 2023-02-23T15:17:10Z | |
dc.date.available | 2023-02-23T15:17:10Z | |
dc.date.issued | 2023 | en |
dc.identifier.citation | De-Colle C, Kirby A, Russell N, Shaitelman SF, Currey A, Donovan E, et al. Adaptive radiotherapy for breast cancer. Clinical and translational radiation oncology. 2023 Mar;39:100564. PubMed PMID: 36632056. Pubmed Central PMCID: PMC9826896. Epub 2023/01/13. eng. | en |
dc.identifier.pmid | 36632056 | en |
dc.identifier.doi | 10.1016/j.ctro.2022.100564 | en |
dc.identifier.uri | http://hdl.handle.net/10541/625997 | |
dc.description.abstract | Research in the field of local and locoregional breast cancer radiotherapy aims to maintain excellent oncological outcomes while reducing treatment-related toxicity. Adaptive radiotherapy (ART) considers variations in target and organs at risk (OARs) anatomy occurring during the treatment course and integrates these in re-optimized treatment plans. Exploiting ART routinely in clinic may result in smaller target volumes and better OAR sparing, which may lead to reduction of acute as well as late toxicities. In this review MR-guided and CT-guided ART for breast cancer patients according to different clinical scenarios (neoadjuvant and adjuvant partial breast irradiation, whole breast, chest wall and regional nodal irradiation) are reviewed and their advantages as well as challenging aspects discussed. | en |
dc.language.iso | en | en |
dc.relation.url | https://dx.doi.org/10.1016/j.ctro.2022.100564 | en |
dc.title | Adaptive radiotherapy for breast cancer | en |
dc.type | Article | en |
dc.contributor.department | Department of Radiation Oncology, University Hospital and Medical Faculty, Eberhard Karls University Tübingen, Tübingen, Germany | en |
dc.identifier.journal | Clinical and Translational Radiation Oncology | en |
dc.description.note | en] | |
refterms.dateFOA | 2023-02-23T15:29:15Z |